Literature DB >> 15517140

[Principles of PET/CT and clinical application].

A Bockisch1, T Beyer, G Antoch, P Veit, S Müller, R Pink, S Rosenbaum, H Kühl.   

Abstract

Medicine today imposes high demands on diagnosing disease. Techniques should be preferably noninvasive, identify the disease at an early stage, and be quick and accurate. Frequently, these demands can only be met by employing various diagnostic modalities. Consequently, the integration of two imaging modalities, such as the combination of PET and CT, increases the quality of coregistration and facilitates a timely diagnosis. However, complex imaging procedures require a judicious choice of the areas of application. If, for example, both PET and CT are indicated then a combined PET/CT exam results in improved diagnosis, whereby the actual benefit will depend upon the clinical problem. Typically we expect an advantage of 10% with PET/CT compared to separate examinations with CT and PET. In addition, PET/CT allows for new indications and applications, which cannot be performed satisfactorily with independent examinations and retrospective image alignment. One example is the application of PET/CT in radiation therapy planning.

Mesh:

Substances:

Year:  2004        PMID: 15517140     DOI: 10.1007/s00117-004-1122-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  24 in total

Review 1.  [Graves' disease nd toxic nodular goiter--radioiodine therapy].

Authors:  H Schicha; M Dietlein
Journal:  Nuklearmedizin       Date:  2002-04       Impact factor: 1.379

2.  Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology.

Authors:  Thomas Beyer; Gerald Antoch; Todd Blodgett; Lutz F Freudenberg; Tim Akhurst; Stephan Mueller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-12       Impact factor: 9.236

3.  Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.

Authors:  Gerald Antoch; Lutz S Freudenberg; Thomas Egelhof; Jörg Stattaus; Walter Jentzen; Jörg F Debatin; Andreas Bockisch
Journal:  J Nucl Med       Date:  2002-10       Impact factor: 10.057

Review 4.  Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfalls.

Authors:  Andreas Bockisch; Thomas Beyer; Gerald Antoch; Lutz S Freudenberg; Hilmar Kühl; Jörg F Debatin; Stefan P Müller
Journal:  Mol Imaging Biol       Date:  2004 Jul-Aug       Impact factor: 3.488

Review 5.  [Clinical value of positron emission tomography in neuromedicine. Position paper on results of an interdisciplinary consensus conference].

Authors:  T Kuwert; P Bartenstein; F Grünwald; K Herholz; R Larisch; O Sabri; H J Biersack; E Moser; H W Müller-Gärtner; O Schober; M Schwaiger; U Büll; W D Heiss
Journal:  Nervenarzt       Date:  1998-12       Impact factor: 1.214

Review 6.  [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology].

Authors: 
Journal:  Z Kardiol       Date:  1996-07

7.  Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Authors:  Jörg Kowalski; Marcus Henze; Jochen Schuhmacher; Helmut R Mäcke; Michael Hofmann; Uwe Haberkorn
Journal:  Mol Imaging Biol       Date:  2003 Jan-Feb       Impact factor: 3.488

8.  Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report.

Authors:  L S Freudenberg; G Antoch; R Görges; J Knust; R Pink; W Jentzen; J F Debatin; W Brandau; A Bockisch; J Stattaus
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

View more
  1 in total

1.  [Department and patient management in radiotherapy. The Freiburg model].

Authors:  Felix Heinemann; Fred Röhner; Marianne Schmucker; Gregor Bruggmoser; Karl Henne; Anca-Ligia Grosu; Hermann Frommhold
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.